What is OneMedNet's operating income?

OneMedNet's total operating income in 2025 was -$9.67 million, based on the following breakdown: Total Gross Profit: -$503 thousand Total Operating Expenses: $9.16 million

OneMedNet (ONMD) Financials

$0.69 -0.07 (-8.67%)

Closing price 07/16/2026 04:00 PM Eastern

Extended Trading

$0.72 +0.03 (+5.06%)

As of 07:06 AM Eastern

Compare

Annual Income Statements for OneMedNet

This table shows OneMedNet's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-30	-34	-10	-2.80
Consolidated Net Income / (Loss)	-30	-34	-10	-2.80
Net Income / (Loss) Continuing Operations	-30	-34	-10	-2.80
Total Pre-Tax Income	-30	-34	-10	-2.80
Total Operating Income	-7.72	-6.85	-9.61	-9.67
Total Gross Profit	-0.36	-0.13	-0.28	-0.50
Total Revenue	1.15	1.02	0.64	1.36
Operating Revenue	1.15	1.02	0.64	1.36
Total Cost of Revenue	1.51	1.15	0.92	1.86
Operating Cost of Revenue	1.51	1.15	0.92	1.86
Total Operating Expenses	7.36	6.72	9.32	9.16
Selling, General & Admin Expense	4.81	3.54	7.03	6.38
Marketing Expense	0.96	1.12	0.83	1.27
Research & Development Expense	1.59	2.07	1.47	1.52
Total Other Income / (Expense), net	-23	-27	-0.52	6.87
Interest Expense	0.00	0.01	0.15	0.11
Other Income / (Expense), net	-23	-27	-0.38	6.98
Income Tax Expense	0.02	0.02	0.00	0.00
Basic Earnings per Share	($7.66)	($4.65)	($0.36)	($0.06)
Weighted Average Basic Shares Outstanding	3.97M	7.27M	28.08M	44.55M
Diluted Earnings per Share	($7.66)	($4.65)	($0.36)	($0.06)
Weighted Average Diluted Shares Outstanding	3.97M	7.27M	28.08M	44.55M
Weighted Average Basic & Diluted Shares Outstanding	7.57M	-	30.76M	52.20M

This table shows OneMedNet's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-14	-2.51	-2.11	-3.59	-2.06	-2.37	-1.90	2.98	-0.74	-3.14	-2.45
Consolidated Net Income / (Loss)	-14	-2.51	-2.11	-3.59	-2.06	-2.37	-1.90	2.98	-0.74	-3.14	-2.45
Net Income / (Loss) Continuing Operations	-14	-2.51	-2.11	-3.59	-2.06	-2.37	-1.90	2.98	-0.74	-3.14	-2.45
Total Pre-Tax Income	-14	-2.50	-2.11	-3.59	-2.06	-2.37	-1.90	2.98	-0.74	-3.14	-2.45
Total Operating Income	-1.93	-1.89	-2.10	-2.45	-2.34	-2.71	-2.22	-2.06	-2.24	-3.15	-2.55
Total Gross Profit	0.03	-0.02	-0.07	-0.10	-0.08	-0.03	-0.22	-0.24	-0.22	0.18	-0.38
Total Revenue	0.33	0.32	0.25	0.23	0.14	0.03	0.14	0.16	0.18	0.89	0.10
Operating Revenue	0.33	0.32	0.25	0.23	0.14	0.03	0.14	0.16	0.18	0.89	0.10
Total Cost of Revenue	0.29	0.34	0.32	0.33	0.23	0.05	0.36	0.40	0.40	0.71	0.48
Operating Cost of Revenue	0.29	0.34	0.32	0.33	0.23	0.05	0.36	0.40	0.40	0.71	0.48
Total Operating Expenses	1.96	1.87	2.03	2.35	2.25	2.69	2.00	1.82	2.01	3.33	2.17
Selling, General & Admin Expense	1.31	1.07	1.36	1.72	1.81	2.14	1.36	1.18	1.39	2.45	1.48
Marketing Expense	0.24	0.30	0.23	0.25	0.14	0.21	0.29	0.26	0.30	0.42	0.38
Research & Development Expense	0.41	0.50	0.45	0.38	0.30	0.34	0.35	0.38	0.32	0.46	0.31
Total Other Income / (Expense), net	-12	-0.61	-0.01	-1.14	0.28	0.34	0.32	5.05	1.49	0.01	0.10
Interest Expense	0.00	0.01	0.04	0.04	0.04	0.03	0.03	0.02	0.05	0.01	0.01
Other Income / (Expense), net	-12	-0.60	0.03	-1.09	0.31	0.37	0.35	5.07	1.54	0.01	0.11
Basic Earnings per Share	($3.23)	$2.90	($0.08)	($0.14)	($0.07)	($0.07)	($0.06)	$0.07	($0.01)	($0.06)	($0.04)
Weighted Average Basic Shares Outstanding	4.28M	7.27M	24.92M	25.18M	29.27M	28.08M	34.10M	36.84M	52.62M	44.55M	55.32M
Diluted Earnings per Share	($3.23)	$2.90	($0.08)	($0.14)	($0.07)	($0.07)	($0.06)	$0.07	($0.01)	($0.06)	($0.04)
Weighted Average Diluted Shares Outstanding	4.28M	7.27M	24.92M	25.18M	29.27M	28.08M	34.10M	38.41M	52.62M	44.55M	55.32M
Weighted Average Basic & Diluted Shares Outstanding	32.26M	0.00	-	-	27.99M	30.76M	30.57M	46.10M	51.01M	52.20M	54.43M

This table details how cash moves in and out of OneMedNet's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-2.82	-0.22	0.13	0.41
Net Cash From Operating Activities	-4.70	-4.79	-6.95	-7.50
Net Cash From Continuing Operating Activities	-7.10	-4.79	-6.95	-7.50
Net Income / (Loss) Continuing Operations	-30	-34	-10	-2.80
Consolidated Net Income / (Loss)	-30	-34	-10	-2.80
Depreciation Expense	0.03	0.03	0.06	0.07
Non-Cash Adjustments To Reconcile Net Income	23	28	1.58	-4.87
Changes in Operating Assets and Liabilities, net	-0.03	0.61	1.54	0.11
Net Cash From Investing Activities	-0.06	-0.04	-1.98	2.31
Net Cash From Continuing Investing Activities	-0.06	-0.04	-1.98	2.31
Purchase of Property, Plant & Equipment	-0.06	-0.04	-0.05	-0.01
Sale of Property, Plant & Equipment	-	0.00	-	5.07
Other Investing Activities, net	-	0.00	-2.90	-2.75
Net Cash From Financing Activities	4.33	4.61	9.06	5.61
Net Cash From Continuing Financing Activities	4.33	4.61	9.06	5.61
Repayment of Debt	-	1.50	-1.06	1.03
Repurchase of Common Equity	-	0.00	0.00	-0.02
Issuance of Debt	5.14	4.63	3.85	2.54
Issuance of Common Equity	-	0.00	6.27	2.50
Other Financing Activities, net	-0.81	-1.53	0.00	-0.44
Cash Interest Paid	-	0.00	0.03	0.02
Cash Income Taxes Paid	-	0.00	0.02	0.00

This table details how cash moves in and out of OneMedNet's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	0.30	-0.57	0.13	0.53	1.23	-1.76	-0.03	-0.02	0.03	0.44	-0.35
Net Cash From Operating Activities	-1.10	-1.73	-1.55	-1.51	-1.90	-2.00	-1.85	-2.28	-1.56	-1.71	-1.54
Net Cash From Continuing Operating Activities	-1.10	-1.73	-1.55	-1.51	-1.90	-2.00	-1.85	-2.28	-1.56	-1.71	-1.54
Net Income / (Loss) Continuing Operations	-14	-2.50	-2.11	-3.59	-2.06	-2.37	-1.90	2.98	-0.74	-3.14	-2.45
Consolidated Net Income / (Loss)	-14	-2.50	-2.11	-3.59	-2.06	-2.37	-1.90	2.98	-0.74	-3.14	-2.45
Depreciation Expense	0.01	0.01	0.01	0.01	0.01	0.03	0.01	0.03	0.01	0.01	0.01
Non-Cash Adjustments To Reconcile Net Income	13	0.65	0.13	1.21	-0.08	0.33	-0.12	-4.86	-1.37	1.47	0.32
Changes in Operating Assets and Liabilities, net	0.03	0.12	0.42	0.87	0.23	0.03	0.16	-0.44	0.54	-0.06	0.58
Net Cash From Investing Activities	-0.02	-0.02	-0.01	-0.00	-2.34	0.37	1.92	-0.67	1.11	-0.05	0.35
Net Cash From Continuing Investing Activities	-0.02	-0.02	-0.01	-0.00	-2.34	0.37	1.92	-0.67	1.11	-0.05	0.35
Purchase of Property, Plant & Equipment	-0.02	-0.02	-0.01	-0.00	-0.01	-0.04	-0.01	-0.00	-	-0.01	-0.00
Other Investing Activities, net	-	-	0.00	-	-2.33	-0.57	1.93	-0.67	1.11	-5.12	0.35
Net Cash From Financing Activities	1.42	1.18	1.68	2.04	5.47	-0.13	-0.09	2.93	0.48	2.20	0.84
Net Cash From Continuing Financing Activities	1.42	1.18	1.68	2.04	5.47	-0.13	-0.09	2.93	0.48	2.20	0.84
Repayment of Debt	-	1.50	-0.03	-0.10	-0.60	-0.33	-0.09	-0.76	0.49	1.31	-0.14
Issuance of Debt	1.88	0.05	1.71	2.14	-	-	0.00	-	-	2.54	0.48
Issuance of Common Equity	-	-	-	-	6.27	-	0.00	-	0.50	-1.70	0.50
Cash Interest Paid	-	-	0.00	-	-	0.03	0.01	0.00	0.03	-0.01	0.01
Cash Income Taxes Paid	-	-	0.02	-	-	-	0.00	-	-	0.00	0.00

This table presents OneMedNet's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	118	1.29	0.46	3.73	2.15
Total Current Assets	0.54	0.39	0.37	3.62	2.10
Cash & Equivalents	0.45	0.27	0.05	0.17	0.59
Short-Term Investments	-	-	0.00	2.85	0.51
Accounts Receivable	-	0.02	0.15	0.21	0.50
Prepaid Expenses	0.08	0.10	0.17	0.39	0.51
Plant, Property, & Equipment, net	0.00	0.08	0.10	0.11	0.06
Total Noncurrent Assets	117	0.82	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	118	1.29	0.46	3.73	2.15
Total Liabilities	9.17	28	14	20	5.12
Total Current Liabilities	0.29	26	14	19	4.83
Short-Term Debt	-	25	5.09	7.06	0.75
Accounts Payable	0.00	1.18	4.68	6.04	3.50
Current Deferred Revenue	-	0.18	3.78	0.56	0.39
Other Current Liabilities	-	0.00	0.28	5.57	0.19
Total Noncurrent Liabilities	8.88	1.54	0.07	0.45	0.29
Long-Term Debt	-	1.50	-	0.00	0.22
Other Noncurrent Operating Liabilities	8.88	0.04	0.07	0.45	0.07
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-8.61	-44	-13	-16	-2.97
Total Preferred & Common Equity	-8.61	-26	-13	-16	-2.97
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-8.61	-44	-13	-16	-2.97
Common Stock	0.00	14	78	86	102
Retained Earnings	-8.61	-58	-91	-102	-104
Treasury Stock	-	-	0.00	-0.53	-0.53

This table presents OneMedNet's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	19	0.75	1.04	4.39	1.73	2.34	1.51	1.51
Total Current Assets	0.02	0.66	0.96	4.30	1.63	2.27	1.45	1.46
Cash & Equivalents	0.00	0.17	0.41	1.93	0.14	0.12	0.15	0.23
Short-Term Investments	-	-	-	-	0.79	1.60	0.60	0.07
Accounts Receivable	-	0.25	0.08	0.06	0.25	0.25	0.58	0.70
Prepaid Expenses	0.02	0.23	0.17	0.15	0.45	0.29	0.12	0.46
Plant, Property, & Equipment, net	0.00	0.09	0.09	0.08	0.10	0.07	0.06	0.05
Total Noncurrent Assets	19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	19	0.75	1.04	4.39	1.73	2.34	1.51	1.51
Total Liabilities	12	16	20	19	18	6.18	5.45	5.59
Total Current Liabilities	3.08	15	20	19	18	6.16	5.01	5.36
Short-Term Debt	-	1.62	4.06	6.89	6.93	0.40	0.39	0.66
Accounts Payable	-	5.88	6.48	6.16	6.87	5.25	3.85	3.94
Current Deferred Revenue	-	0.46	0.52	0.43	3.77	0.51	0.77	0.68
Other Current Liabilities	0.01	6.71	8.99	5.15	0.59	0.00	0.00	0.07
Total Noncurrent Liabilities	8.66	1.79	0.18	0.03	0.13	0.02	0.44	0.23
Long-Term Debt	4.03	1.78	-	-	-	-	-	0.18
Other Noncurrent Operating Liabilities	4.63	0.02	0.18	0.03	0.13	0.02	0.44	0.06
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-12	-16	-19	-14	-17	-3.84	-3.94	-4.08
Total Preferred & Common Equity	-12	-16	-19	-14	-17	-3.84	-3.94	-4.08
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-12	-16	-19	-14	-17	-3.84	-3.94	-4.08
Common Stock	0.92	78	78	85	87	97	98	103
Retained Earnings	-13	-94	-97	-99	-103	-100	-101	-107
Treasury Stock	-	-0.53	-0.53	-0.53	-0.53	-0.53	-0.53	-0.53

This table displays calculated financial ratios and metrics derived from OneMedNet's official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	14,960,175.00	32,263,342.00	27,987,427.00	51,005,205.00
DEI Adjusted Shares Outstanding	14,960,175.00	32,263,342.00	27,987,427.00	51,005,205.00
DEI Earnings Per Adjusted Shares Outstanding	-2.04	-1.05	-0.36	-0.05
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	-11.45%	-37.02%	111.35%
EBITDA Growth	0.00%	-10.90%	70.58%	73.53%
EBIT Growth	0.00%	-10.90%	70.43%	73.03%
NOPAT Growth	0.00%	11.17%	-40.16%	-0.65%
Net Income Growth	0.00%	-10.93%	70.01%	72.35%
EPS Growth	0.00%	39.30%	92.26%	83.33%
Operating Cash Flow Growth	0.00%	-1.87%	-45.11%	-7.93%
Free Cash Flow Firm Growth	0.00%	0.00%	-199.89%	-386.23%
Invested Capital Growth	0.00%	-2,069.25%	-41.88%	74.12%
Revenue Q/Q Growth	0.00%	-44.87%	-31.52%	174.55%
EBITDA Q/Q Growth	0.00%	47.32%	1.57%	-44.18%
EBIT Q/Q Growth	0.00%	47.28%	1.39%	-41.39%
NOPAT Q/Q Growth	0.00%	36.29%	-9.43%	-4.67%
Net Income Q/Q Growth	0.00%	47.80%	1.36%	-37.71%
EPS Q/Q Growth	0.00%	70.29%	-113.79%	14.29%
Operating Cash Flow Q/Q Growth	0.00%	31.29%	-4.06%	4.02%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-121.69%	-35.90%
Invested Capital Q/Q Growth	0.00%	-172.25%	-27.92%	28.33%
Profitability Metrics	-	-	-	-
Gross Margin	-31.22%	-12.63%	-43.70%	-37.01%
EBITDA Margin	-2,637.38%	-3,302.94%	-1,543.23%	-193.30%
Operating Margin	-669.12%	-671.20%	-1,493.78%	-711.33%
EBIT Margin	-2,639.55%	-3,305.68%	-1,552.10%	-198.09%
Profit (Net Income) Margin	-2,641.02%	-3,308.52%	-1,575.27%	-206.11%
Tax Burden Percent	100.06%	100.05%	100.02%	100.04%
Interest Burden Percent	100.00%	100.03%	101.47%	104.01%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-73.97%	169.74%	68.92%	29.62%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-51.09%	-3,850.66%	-476.26%	-91.60%
Return on Assets (ROA)	-51.12%	-3,853.96%	-483.37%	-95.30%
Return on Common Equity (ROCE)	47.27%	244.99%	68.92%	29.62%
Return on Equity Simple (ROE_SIMPLE)	115.52%	251.30%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-5.40	-4.80	-6.72	-6.77
NOPAT Margin	-468.39%	-469.84%	-1,045.65%	-497.93%
Net Nonoperating Expense Percent (NNEP)	96.45%	186.87%	74.96%	-202.24%
Return On Investment Capital (ROIC_SIMPLE)	-	57.46%	75.63%	339.87%
Cost of Revenue to Revenue	131.22%	112.63%	143.70%	137.01%
SG&A Expenses to Revenue	416.83%	347.11%	1,092.85%	469.24%
R&D to Revenue	137.99%	202.25%	228.15%	111.48%
Operating Expenses to Revenue	637.90%	658.57%	1,450.08%	674.32%
Earnings before Interest and Taxes (EBIT)	-30	-34	-9.98	-2.69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-30	-34	-9.92	-2.63
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	135.46	25.60	59.20	41.28
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	173.29	30.54	65.48	41.20
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	9.71	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	-1.00	-0.38	-0.44	-0.33
Long-Term Debt to Equity	-0.06	0.00	0.00	-0.07
Financial Leverage	-0.99	-0.78	-0.31	-0.21
Leverage Ratio	1.45	-0.04	-0.14	-0.31
Compound Leverage Factor	1.45	-0.04	-0.14	-0.32
Debt to Total Capital	-22,623.28%	-61.02%	-79.42%	-48.92%
Short-Term Debt to Total Capital	-21,330.17%	-61.02%	-79.42%	-37.87%
Long-Term Debt to Total Capital	-1,293.10%	0.00%	0.00%	-11.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-15,210.34%	0.00%	0.00%	0.00%
Common Equity to Total Capital	37,933.62%	161.02%	179.42%	148.92%
Debt to EBITDA	-0.86	-0.15	-0.71	-0.37
Net Debt to EBITDA	-0.85	-0.15	-0.41	0.04
Long-Term Debt to EBITDA	-0.05	0.00	0.00	-0.08
Debt to NOPAT	-4.86	-1.06	-1.05	-0.14
Net Debt to NOPAT	-4.81	-1.05	-0.60	0.02
Long-Term Debt to NOPAT	-0.28	0.00	0.00	-0.03
Altman Z-Score	-160.19	-547.45	-50.68	-66.37
Noncontrolling Interest Sharing Ratio	163.90%	-44.33%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.02	0.03	0.19	0.43
Quick Ratio	0.01	0.01	0.17	0.33
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	3.21	-3.21	-16
Operating Cash Flow to CapEx	-8,108.62%	-10,888.64%	-13,631.37%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	291.90	-21.82	-144.41
Operating Cash Flow to Interest Expense	0.00	-435.55	-47.29	-69.47
Operating Cash Flow Less CapEx to Interest Expense	0.00	-439.55	-47.64	-22.65
Efficiency Ratios	-	-	-	-
Asset Turnover	0.02	1.16	0.31	0.46
Accounts Receivable Turnover	0.00	11.94	3.52	3.84
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	11.22	6.21	16.57
Accounts Payable Turnover	0.00	0.39	0.17	0.39
Days Sales Outstanding (DSO)	0.00	30.57	103.60	95.08
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	929.80	2,117.32	934.45
Cash Conversion Cycle (CCC)	0.00	-899.23	-2,013.72	-839.38
Capital & Investment Metrics	-	-	-	-
Invested Capital	-0.39	-8.40	-12	-3.08
Invested Capital Turnover	-2.98	-0.23	-0.06	-0.18
Increase / (Decrease) in Invested Capital	0.00	-8.01	-3.52	8.83
Enterprise Value (EV)	200	31	42	56
Market Capitalization	156	26	38	56
Book Value per Share	($2.94)	($0.42)	($0.57)	($0.06)
Tangible Book Value per Share	($2.94)	($0.42)	($0.57)	($0.06)
Total Capital	-0.12	-8.35	-8.89	-1.99
Total Debt	26	5.09	7.06	0.97
Total Long-Term Debt	1.50	0.00	0.00	0.22
Net Debt	26	5.05	4.04	-0.12
Capital Expenditures (CapEx)	0.06	0.04	0.05	-5.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.24	-8.43	-12	-3.07
Debt-free Net Working Capital (DFNWC)	-0.97	-8.38	-8.55	-1.98
Net Working Capital (NWC)	-26	-13	-16	-2.73
Net Nonoperating Expense (NNE)	25	29	3.41	-3.97
Net Nonoperating Obligations (NNO)	26	5.05	4.04	-0.12
Total Depreciation and Amortization (D&A)	0.03	0.03	0.06	0.07
Debt-free, Cash-free Net Working Capital to Revenue	-107.63%	-825.27%	-1,799.38%	-225.68%
Debt-free Net Working Capital to Revenue	-84.13%	-820.67%	-1,329.55%	-145.40%
Net Working Capital to Revenue	-2,230.10%	-1,319.59%	-2,427.53%	-200.88%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.06	$0.00	($0.36)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	12.13M	0.00	28.08M	44.55M
Adjusted Diluted Earnings per Share	$0.03	$0.00	($0.36)	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	12.13M	0.00	28.08M	44.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.57M	0.00	30.76M	52.20M
Normalized Net Operating Profit after Tax (NOPAT)	-5.40	-4.80	-6.72	-6.77
Normalized NOPAT Margin	-468.39%	-469.84%	-1,045.65%	-497.93%
Pre Tax Income Margin	-2,639.55%	-3,306.76%	-1,574.96%	-206.03%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	-3,068.27	-67.89	-24.93
NOPAT to Interest Expense	0.00	-436.10	-45.74	-62.66
EBIT Less CapEx to Interest Expense	0.00	-3,072.27	-68.24	21.90
NOPAT Less CapEx to Interest Expense	0.00	-440.10	-46.09	-15.83
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-0.68%

This table displays calculated financial ratios and metrics derived from OneMedNet's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	7,570,336.00	32,263,342.00	32,263,342.00	23,850,010.00	23,850,010.00	27,987,427.00	30,760,576.00	30,572,831.00	46,095,647.00	51,005,205.00	52,196,729.00
DEI Adjusted Shares Outstanding	7,570,336.00	32,263,342.00	32,263,342.00	23,850,010.00	23,850,010.00	27,987,427.00	30,760,576.00	30,572,831.00	46,095,647.00	51,005,205.00	52,196,729.00
DEI Earnings Per Adjusted Shares Outstanding	-1.83	-0.08	-0.07	-0.15	-0.09	-0.08	-0.06	0.10	-0.02	-0.06	-0.05
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-72.07%	24.00%	31.21%	-56.44%	-91.93%	-44.76%	-31.72%	24.65%	3,323.08%	-29.93%
EBITDA Growth	-2,082.52%	92.44%	73.71%	63.12%	85.46%	6.38%	9.58%	185.87%	66.00%	-34.74%	-30.82%
EBIT Growth	-2,083.47%	92.42%	73.59%	63.05%	85.39%	5.68%	9.48%	184.67%	65.68%	-33.63%	-30.57%
NOPAT Growth	-270.56%	67.43%	-43.02%	-56.21%	-21.22%	-43.90%	-5.85%	-20.10%	4.32%	-15.88%	-14.75%
Net Income Growth	-8,929.52%	92.49%	73.05%	62.62%	85.13%	5.57%	9.82%	183.09%	63.99%	-32.32%	-28.97%
EPS Growth	-16,250.00%	135.80%	95.88%	94.12%	97.83%	-102.41%	25.00%	150.00%	85.71%	14.29%	33.33%
Operating Cash Flow Growth	-213.51%	55.84%	-54.39%	-56.22%	-73.00%	-15.71%	-19.84%	-51.66%	18.13%	14.18%	16.83%
Free Cash Flow Firm Growth	5,825.28%	0.00%	-65.30%	-62.55%	-80.91%	-75.83%	-111.18%	-137.09%	-134.08%	-782.50%	-153.39%
Invested Capital Growth	-89.81%	-2,069.25%	-162.14%	-178.31%	-180.13%	-41.88%	15.38%	67.41%	53.82%	74.12%	66.47%
Revenue Q/Q Growth	88.44%	-1.23%	-22.98%	-8.47%	-37.44%	-81.69%	426.92%	13.14%	14.19%	402.82%	-89.21%
EBITDA Q/Q Growth	-44.19%	82.11%	16.93%	-72.08%	43.13%	-15.16%	19.77%	263.42%	-122.51%	-356.43%	22.10%
EBIT Q/Q Growth	-44.15%	82.05%	16.79%	-71.65%	43.01%	-15.88%	20.15%	260.56%	-123.10%	-351.15%	21.97%
NOPAT Q/Q Growth	-22.66%	2.13%	-11.40%	-16.80%	4.81%	-16.18%	18.05%	-32.52%	24.16%	-40.72%	18.86%
Net Income Q/Q Growth	-44.15%	81.84%	16.08%	-70.18%	42.66%	-15.31%	19.85%	256.78%	-124.85%	-323.75%	21.88%
EPS Q/Q Growth	-35.71%	189.78%	-102.76%	-75.00%	50.00%	0.00%	14.29%	216.67%	-114.29%	-500.00%	33.33%
Operating Cash Flow Q/Q Growth	-14.11%	-56.82%	10.32%	2.65%	-26.36%	-4.89%	7.11%	-17.25%	31.79%	-9.95%	9.98%
Free Cash Flow Firm Q/Q Growth	10.27%	-93.38%	364.98%	10.40%	-43.80%	-91.62%	-315.06%	-266.39%	48.37%	-67.75%	20.15%
Invested Capital Q/Q Growth	-42.53%	-172.25%	-48.67%	-26.85%	41.19%	-27.92%	11.33%	51.15%	16.67%	28.33%	-14.89%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	10.12%	-4.97%	-27.82%	-44.93%	-59.15%	-100.00%	-163.50%	-155.48%	-125.42%	20.67%	-395.83%
EBITDA Margin	-4,243.56%	-768.63%	-829.03%	-1,558.59%	-1,416.90%	-8,911.54%	-1,356.93%	1,960.00%	-386.44%	-350.79%	-2,533.33%
Operating Margin	-591.10%	-585.71%	-847.18%	-1,081.06%	-1,645.07%	-10,438.46%	-1,623.36%	-1,330.97%	-1,262.71%	-353.37%	-2,658.33%
EBIT Margin	-4,245.40%	-771.43%	-833.47%	-1,563.00%	-1,423.94%	-9,011.54%	-1,365.69%	1,938.06%	-392.09%	-351.80%	-2,544.79%
Profit (Net Income) Margin	-4,245.40%	-780.43%	-850.40%	-1,581.06%	-1,449.30%	-9,126.92%	-1,388.32%	1,923.87%	-418.64%	-352.81%	-2,555.21%
Tax Burden Percent	100.00%	100.72%	100.00%	100.00%	100.00%	100.08%	100.00%	100.00%	100.00%	100.03%	100.00%
Interest Burden Percent	100.00%	100.44%	102.03%	101.16%	101.78%	101.20%	101.66%	99.27%	106.77%	100.26%	100.41%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-12.20%	0.00%	-166.70%	-387.61%	-936.73%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-402.70%	0.00%	-203.72%	-488.23%	-946.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-21.60%	0.00%	-169.03%	-2,728.52%	1,273.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-33.80%	169.74%	-335.73%	-3,116.13%	336.37%	68.92%	61.53%	29.11%	22.34%	29.62%	32.50%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-112.56%	-898.61%	-58.45%	-113.16%	-112.74%	-2,765.17%	-585.45%	527.83%	-65.86%	-162.67%	-2,071.03%
Return on Assets (ROA)	-112.56%	-909.10%	-59.64%	-114.46%	-114.75%	-2,800.58%	-595.15%	523.97%	-70.32%	-163.14%	-2,079.51%
Return on Common Equity (ROCE)	5.69%	244.99%	2,033.54%	137,060.09%	1,303.60%	68.92%	61.53%	29.11%	22.34%	29.62%	32.50%
Return on Equity Simple (ROE_SIMPLE)	556.77%	0.00%	178.73%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.35	-1.32	-1.47	-1.72	-1.64	-1.90	-1.56	-2.06	-1.56	-2.20	-1.79
NOPAT Margin	-413.77%	-410.00%	-593.02%	-756.74%	-1,151.55%	-7,306.92%	-1,136.35%	-1,330.97%	-883.90%	-247.36%	-1,860.83%
Net Nonoperating Expense Percent (NNEP)	390.51%	7.69%	37.01%	100.62%	9.41%	10.42%	7.50%	-495.82%	-35.84%	47.86%	20.43%
Return On Investment Capital (ROIC_SIMPLE)	17.78%	15.81%	11.95%	11.36%	22.17%	21.37%	16.17%	59.97%	44.06%	110.57%	55.10%
Cost of Revenue to Revenue	89.88%	104.97%	127.82%	144.93%	159.15%	200.00%	263.50%	255.48%	225.42%	79.33%	495.83%
SG&A Expenses to Revenue	402.45%	331.99%	547.58%	755.95%	1,277.46%	8,226.92%	994.16%	763.23%	783.05%	274.83%	1,544.79%
R&D to Revenue	124.23%	154.97%	179.44%	168.72%	209.86%	1,311.54%	254.01%	246.45%	182.49%	51.91%	323.96%
Operating Expenses to Revenue	601.23%	580.75%	819.35%	1,036.12%	1,585.92%	10,338.46%	1,459.85%	1,175.48%	1,137.29%	374.04%	2,262.50%
Earnings before Interest and Taxes (EBIT)	-14	-2.48	-2.07	-3.55	-2.02	-2.34	-1.87	3.00	-0.69	-3.13	-2.44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-14	-2.48	-2.06	-3.54	-2.01	-2.32	-1.86	3.04	-0.68	-3.12	-2.43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	46.03	25.60	21.43	20.87	15.53	59.20	28.41	37.89	101.50	41.28	33.67
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	9.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	58.58	30.54	24.44	23.85	20.81	65.48	39.66	35.02	100.77	41.20	34.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	9.71	0.96	0.89	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	-0.38	-0.22	-0.21	-0.48	-0.44	-0.42	-0.10	-0.10	-0.33	-0.21
Long-Term Debt to Equity	0.53	0.00	-0.11	0.00	0.00	0.00	0.00	0.00	0.00	-0.07	-0.04
Financial Leverage	0.05	-0.78	0.83	5.59	-1.35	-0.31	-0.29	-0.09	-0.25	-0.21	-0.32
Leverage Ratio	1.17	-0.04	7.33	46.61	-3.55	-0.14	-0.08	-0.15	-0.32	-0.31	-0.16
Compound Leverage Factor	1.17	-0.04	7.48	47.15	-3.61	-0.14	-0.08	-0.15	-0.35	-0.31	-0.16
Debt to Total Capital	34.71%	-61.02%	-27.58%	-26.86%	-93.41%	-79.42%	-71.95%	-11.63%	-10.93%	-48.92%	-25.82%
Short-Term Debt to Total Capital	0.00%	-61.02%	-13.14%	-26.86%	-93.41%	-79.42%	-71.95%	-11.63%	-10.93%	-37.87%	-20.39%
Long-Term Debt to Total Capital	34.71%	0.00%	-14.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-11.05%	-5.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	165.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-100.01%	161.02%	127.58%	126.86%	193.41%	179.42%	171.95%	111.63%	110.93%	148.92%	125.82%
Debt to EBITDA	-0.06	-0.15	-0.12	-0.19	-0.68	-0.71	-0.71	-0.13	-0.21	-0.37	-0.26
Net Debt to EBITDA	-0.06	-0.15	-0.12	-0.15	-0.49	-0.41	-0.62	0.42	0.20	0.04	-0.17
Long-Term Debt to EBITDA	-0.06	0.00	-0.06	0.00	0.00	0.00	0.00	0.00	0.00	-0.08	-0.06
Debt to NOPAT	-0.54	-1.06	-0.65	-0.69	-1.12	-1.05	-1.02	-0.06	-0.06	-0.14	-0.12
Net Debt to NOPAT	-0.54	-1.05	-0.61	-0.57	-0.81	-0.60	-0.88	0.20	0.06	0.02	-0.08
Long-Term Debt to NOPAT	-0.54	0.00	-0.34	0.00	0.00	0.00	0.00	0.00	0.00	-0.03	-0.03
Altman Z-Score	0.99	-325.08	-203.86	-162.12	-36.40	-43.92	-97.85	-56.07	-92.60	-67.04	-102.05
Noncontrolling Interest Sharing Ratio	116.83%	-44.33%	705.70%	4,498.41%	-287.55%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.01	0.03	0.04	0.05	0.23	0.19	0.09	0.37	0.29	0.43	0.27
Quick Ratio	0.00	0.01	0.03	0.02	0.11	0.17	0.07	0.32	0.27	0.33	0.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	101	6.69	31	34	19	1.62	-3.48	-13	-6.58	-11	-8.81
Operating Cash Flow to CapEx	-5,238.10%	-10,781.25%	-25,783.33%	-150,600.00%	-21,144.44%	-5,702.86%	-37,080.00%	-76,133.33%	0.00%	-34,260.00%	-77,100.00%
Free Cash Flow to Firm to Interest Expense	0.00	607.98	740.40	837.34	535.99	57.72	-112.12	-578.86	-139.90	-1,378.81	-880.74
Operating Cash Flow to Interest Expense	0.00	-156.82	-36.83	-36.73	-52.86	-71.29	-59.81	-103.82	-33.15	-214.13	-154.20
Operating Cash Flow Less CapEx to Interest Expense	0.00	-158.27	-36.98	-36.76	-53.11	-72.54	-59.97	-103.95	-33.15	-214.75	-154.40
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.03	1.16	0.07	0.07	0.08	0.31	0.43	0.27	0.17	0.46	0.81
Accounts Receivable Turnover	0.00	11.94	0.00	0.00	0.00	3.52	2.13	2.80	1.53	3.84	2.79
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	11.22	0.00	0.00	0.00	6.21	5.46	5.94	6.88	16.57	17.81
Accounts Payable Turnover	0.00	0.39	0.40	0.00	0.00	0.17	0.15	0.18	0.24	0.39	0.37
Days Sales Outstanding (DSO)	0.00	30.57	0.00	0.00	0.00	103.60	171.52	130.53	237.80	95.08	130.71
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	929.80	911.91	0.00	0.00	2,117.32	2,402.85	2,067.28	1,511.97	934.45	997.98
Cash Conversion Cycle (CCC)	0.00	-899.23	-911.91	0.00	0.00	-2,013.72	-2,231.33	-1,936.75	-1,274.17	-839.38	-867.27
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	12	-8.40	-12	-16	-9.31	-12	-11	-5.16	-4.30	-3.08	-3.54
Invested Capital Turnover	0.03	-0.23	0.28	0.51	0.81	-0.06	-0.05	-0.04	-0.07	-0.18	-0.19
Increase / (Decrease) in Invested Capital	-102	-8.01	-33	-36	-21	-3.52	1.92	11	5.01	8.83	7.02
Enterprise Value (EV)	108	31	26	27	20	42	21	16	50	56	45
Market Capitalization	85	26	23	23	15	38	15	17	50	56	44
Book Value per Share	($1.54)	($0.42)	($0.49)	($0.80)	($0.60)	($0.57)	($0.59)	($0.13)	($0.09)	($0.06)	($0.08)
Tangible Book Value per Share	($1.54)	($0.42)	($0.49)	($0.80)	($0.60)	($0.57)	($0.59)	($0.13)	($0.09)	($0.06)	($0.08)
Total Capital	12	-8.35	-12	-15	-7.38	-8.89	-9.63	-3.44	-3.55	-1.99	-3.24
Total Debt	4.03	5.09	3.39	4.06	6.89	7.06	6.93	0.40	0.39	0.97	0.84
Total Long-Term Debt	4.03	0.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.18
Net Debt	4.03	5.05	3.22	3.36	4.96	4.04	5.99	-1.32	-0.36	-0.12	0.54
Capital Expenditures (CapEx)	0.02	0.02	0.01	0.00	0.01	0.04	0.01	0.00	0.00	0.01	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.06	-8.43	-13	-16	-9.37	-12	-11	-5.21	-3.92	-3.07	-3.53
Debt-free Net Working Capital (DFNWC)	-3.06	-8.38	-12	-15	-7.43	-8.55	-9.60	-3.49	-3.17	-1.98	-3.23
Net Working Capital (NWC)	-3.06	-13	-14	-19	-14	-16	-17	-3.89	-3.56	-2.73	-3.90
Net Nonoperating Expense (NNE)	12	1.19	0.64	1.87	0.42	0.47	0.35	-5.05	-0.82	0.94	0.67
Net Nonoperating Obligations (NNO)	4.03	5.05	3.22	3.36	4.96	4.04	5.99	-1.32	-0.36	-0.12	0.54
Total Depreciation and Amortization (D&A)	0.01	0.01	0.01	0.01	0.01	0.03	0.01	0.03	0.01	0.01	0.01
Debt-free, Cash-free Net Working Capital to Revenue	-165.16%	-825.27%	-1,174.84%	-1,401.16%	-997.55%	-1,799.38%	-1,980.26%	-1,133.04%	-791.92%	-225.68%	-268.06%
Debt-free Net Working Capital to Revenue	-165.07%	-820.67%	-1,158.56%	-1,338.20%	-791.59%	-1,329.55%	-1,804.14%	-759.13%	-640.61%	-145.40%	-245.37%
Net Working Capital to Revenue	-165.07%	-1,319.59%	-1,309.82%	-1,699.91%	-1,525.45%	-2,427.53%	-3,105.83%	-846.09%	-718.99%	-200.88%	-295.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.24)	$2.90	($0.09)	($0.15)	($0.07)	($0.07)	($0.06)	$0.07	($0.01)	($0.06)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	7.01M	7.27M	23.68M	23.94M	27.88M	28.08M	34.10M	36.84M	52.62M	44.55M	55.32M
Adjusted Diluted Earnings per Share	($0.24)	$2.90	($0.09)	($0.15)	($0.07)	($0.07)	($0.06)	$0.07	($0.01)	($0.06)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	7.01M	7.27M	23.68M	23.94M	27.88M	28.08M	34.10M	38.41M	52.62M	44.55M	55.32M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.26M	0.00	0.00	0.00	27.99M	30.76M	30.57M	46.10M	51.01M	52.20M	54.43M
Normalized Net Operating Profit after Tax (NOPAT)	-1.35	-1.32	-1.47	-1.72	-1.64	-1.90	-1.56	-1.44	-1.56	-2.20	-1.79
Normalized NOPAT Margin	-413.77%	-410.00%	-593.02%	-756.74%	-1,151.55%	-7,306.92%	-1,136.35%	-931.68%	-883.90%	-247.36%	-1,860.83%
Pre Tax Income Margin	-4,245.40%	-774.84%	-850.40%	-1,581.06%	-1,449.30%	-9,119.23%	-1,388.32%	1,923.87%	-418.64%	-352.70%	-2,555.21%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-225.82	-49.21	-86.54	-56.17	-83.68	-60.35	136.55	-14.77	-391.38	-244.30
NOPAT to Interest Expense	0.00	-120.02	-35.02	-41.90	-45.42	-67.85	-50.22	-93.77	-33.29	-275.19	-178.64
EBIT Less CapEx to Interest Expense	0.00	-227.27	-49.36	-86.56	-56.42	-84.93	-60.52	136.41	-14.77	-392.00	-244.50
NOPAT Less CapEx to Interest Expense	0.00	-121.47	-35.16	-41.92	-45.67	-69.10	-50.38	-93.91	-33.29	-275.81	-178.84
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	-0.97%	0.00%	0.00%	0.00%	-5.46%	-0.68%	0.00%

Financials Breakdown Chart

OneMedNet Financials - Frequently Asked Questions

According to the most recent income statement we have on file, OneMedNet's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

OneMedNet's net income appears to be on a downward trend, with a most recent value of -$2.80 million in 2025, falling from -$30.45 million in 2022. The previous period was -$10.13 million in 2024. Check out OneMedNet's forecast to explore projected trends and price targets.

OneMedNet's total operating income in 2025 was -$9.67 million, based on the following breakdown:

Total Gross Profit: -$503 thousand
Total Operating Expenses: $9.16 million

Over the last 3 years, OneMedNet's total revenue changed from $1.15 million in 2022 to $1.36 million in 2025, a change of 17.9%.

OneMedNet's total liabilities were at $5.12 million at the end of 2025, a 74.0% decrease from 2024, and a 44.2% decrease since 2021.

In the past 4 years, OneMedNet's cash and equivalents has ranged from $47 thousand in 2023 to $585 thousand in 2025, and is currently $585 thousand as of their latest financial filing in 2025.

Over the last 3 years, OneMedNet's book value per share changed from -2.94 in 2022 to -0.06 in 2025, a change of -98.0%.

Related Companies

Financial statements for NASDAQ:ONMD last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OneMedNet (ONMD) Financials

Financials Breakdown Chart

OneMedNet Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OneMedNet (ONMD) Financials

Annual Income Statements for OneMedNet

Quarterly Income Statements for OneMedNet

Annual Cash Flow Statements for OneMedNet

Quarterly Cash Flow Statements for OneMedNet

Annual Balance Sheets for OneMedNet

Quarterly Balance Sheets for OneMedNet

Annual Metrics And Ratios for OneMedNet

Quarterly Metrics And Ratios for OneMedNet

Financials Breakdown Chart

OneMedNet Financials - Frequently Asked Questions

When does OneMedNet's fiscal year end?

How has OneMedNet's net income changed over the last 3 years?

What is OneMedNet's operating income?

How has OneMedNet's revenue changed over the last 3 years?

How much debt does OneMedNet have?

How much cash does OneMedNet have?

How has OneMedNet's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools